Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Rhea-AI Summary

Illumina (NASDAQ: ILMN) has announced a live webcast of its upcoming investor session at the Advances in Genome Biology and Technology (AGBT) Conference. The investor fireside chat is scheduled for Tuesday, February 25, 2025, at 8:00am PT (11:00am ET).

The session will feature presentations from key executives including Jacob Thaysen (CEO), Ankur Dhingra (CFO), and Steve Barnard (CTO). Investors, analysts, and interested parties can access the webcast through Illumina's website Investor Info section or via the provided direct link.

Participants are advised to join ten minutes before the scheduled start time to ensure proper connection. A replay of the session will be available on Illumina's website for at least 30 days after the event.

SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference. 

The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer).

Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link – (https://illumina-agbt-investor-session-feb-2025.open-exchange.net/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session.

A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.

Investors: 
Salli Schwartz 
+1.858.291.6421
ir@illumina.com 

Media:
Bonny Fowler
+1.740.641.5579
pr@illumina.com

View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference-302379336.html

SOURCE Illumina, Inc.

FAQ

When is Illumina's (ILMN) AGBT investor session scheduled for 2025?

Illumina's AGBT investor session is scheduled for Tuesday, February 25, 2025, at 8:00am Pacific Time (11:00am Eastern Time).

Which executives will present at Illumina's (ILMN) 2025 AGBT investor session?

The session will feature CEO Jacob Thaysen, CFO Ankur Dhingra, and CTO Steve Barnard.

How can investors access Illumina's (ILMN) AGBT conference webcast?

Investors can access the webcast through Illumina's website Investor Info section or through the provided direct link.

How long will the replay of Illumina's (ILMN) 2025 AGBT investor session be available?

The replay will be available on Illumina's website for at least 30 days following the event.

What format will Illumina's (ILMN) AGBT investor presentation take?

The presentation will be conducted as a fireside chat featuring key executive leadership.